Peter J Neumann

Peter J Neumann

UNVERIFIED PROFILE

Are you Peter J Neumann?   Register this Author

Register author
Peter J Neumann

Peter J Neumann

Publications by authors named "Peter J Neumann"

Are you Peter J Neumann?   Register this Author

100Publications

1575Reads

31Profile Views

Variation in US private health plans' coverage of orphan drugs.

Am J Manag Care 2019 Oct;25(10):508-512

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St #63, Boston, MA 02111. Email:

View Article

Download full-text PDF

Source
October 2019

Yes, Improve the US Value Frameworks, But Recognize They Are Already in Prime Time.

Authors:
Peter J Neumann

Value Health 2019 Sep 26;22(9):975-976. Epub 2019 Jul 26.

Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2019.04.1929DOI Listing
September 2019

Cost-Effectiveness Studies in the ICU: A Systematic Review.

Crit Care Med 2019 Aug;47(8):1011-1017

Sinai Health System and the Department of Medicine, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000003768DOI Listing
August 2019

Embracing the science of value in health.

CMAJ 2019 Jul;191(26):E733-E736

Toronto Health Economics and Technology Assessment Collaborative (Krahn); Toronto General Hospital Research Institute (Krahn), Toronto, Toronto, Ont.; BC SUPPORT Unit (Bryan), BC Academic Health Science Network, Vancouver, BC; School of Population and Public Health (Bryan), University of British Columbia; Centre for Clinical Epidemiology & Evaluation (Bryan), Vancouver Coastal Health Research Institute, Vancouver, BC; Canadian Agency for Drugs and Technologies in Health (Lee); School of Epidemiology and Public Health (Lee), University of Ottawa, Ottawa, Ont.; Center for the Evaluation of Value and Risk in Health ( Neumann), Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Mass.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.181606DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606418PMC
July 2019

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy.

Value Health 2019 06 17;22(6):661-668. Epub 2019 May 17.

Public Health Department, Aix-Marseille University, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2019.03.012DOI Listing
June 2019

Correction to: Publication of Decision Model Source Code: Attitudes of Health Economics Authors.

Pharmacoeconomics 2019 Jun 19. Epub 2019 Jun 19.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-019-00813-5DOI Listing
June 2019

Publication of Decision Model Source Code: Attitudes of Health Economics Authors.

Pharmacoeconomics 2019 May 8. Epub 2019 May 8.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-019-00796-3DOI Listing
May 2019

Taking stock of cost-effectiveness analysis of healthcare in China.

BMJ Glob Health 2019 14;4(3):e001418. Epub 2019 May 14.

Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjgh-2019-001418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528776PMC
May 2019

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions.

Pharmacoeconomics 2019 Apr;37(4):597-608

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Box #63, Boston, MA, 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-019-00788-3DOI Listing
April 2019

Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency.

Health Aff (Millwood) 2019 01;38(1):60-67

Peter J. Neumann is a professor of medicine in the School of Medicine, Tufts University, and director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center.

View Article

Download full-text PDF

Source
http://www.healthaffairs.org/doi/10.1377/hlthaff.2018.05148
Publisher Site
http://dx.doi.org/10.1377/hlthaff.2018.05148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409129PMC
January 2019

Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies.

J Manag Care Spec Pharm 2018 Dec;24(12):1240-1246

1 The Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://www.jmcp.org/doi/10.18553/jmcp.2018.24.12.1240
Publisher Site
http://dx.doi.org/10.18553/jmcp.2018.24.12.1240DOI Listing
December 2018

Risk-Targeted Lung Cancer Screening.

Ann Intern Med 2018 08;169(3):200-201

Tufts Medical Center, Boston, Massachusetts (V.K., J.T.C., P.J.N., D.M.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/L18-0237DOI Listing
August 2018

Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia.

J Manag Care Spec Pharm 2018 Jul;24(7):632-642

1 Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2018.24.7.632DOI Listing
July 2018

Specialty Drug Coverage Varies Across Commercial Health Plans In The US.

Health Aff (Millwood) 2018 07;37(7):1041-1047

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2017.1553DOI Listing
July 2018

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.

Value Health 2018 07 21;21(7):759-761. Epub 2018 Feb 21.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2017.12.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041503PMC
July 2018

Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions.

Int J Cardiol 2018 06;261:103-108

Division of Cardiology, Cardiovascular Center, Tufts Medical Center, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2018.03.024DOI Listing
June 2018

QALYs in 2018-Advantages and Concerns.

JAMA 2018 Jun;319(24):2473-2474

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2018.6072DOI Listing
June 2018

Patient Variability Seldom Assessed in Cost-effectiveness Studies.

Med Decis Making 2018 05 19;38(4):487-494. Epub 2018 Jan 19.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X17746989DOI Listing
May 2018

A Call for Open-Source Cost-Effectiveness Analysis.

Ann Intern Med 2018 04;168(7):529

Tufts Medical Center, Boston, Massachusetts (J.T.C., P.J.N., J.B.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/L17-0695DOI Listing
April 2018

Insurance coverage for genomic tests.

Science 2018 Apr 19;360(6386):278-279. Epub 2018 Apr 19.

Center for Business Models in Healthcare, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://www.sciencemag.org/lookup/doi/10.1126/science.aas9268
Publisher Site
http://dx.doi.org/10.1126/science.aas9268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991085PMC
April 2018

A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures.

Value Health 2018 04 6;21(4):400-406. Epub 2017 Dec 6.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2017.10.007DOI Listing
April 2018

Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures.

Gates Open Res 2018 5;2. Epub 2018 Mar 5.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/gatesopenres.12786.2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801595.2PMC
March 2018

Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients.

Value Health 2018 03 21;21(3):304-309. Epub 2017 Sep 21.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2017.02.008DOI Listing
March 2018

Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.

Ann Intern Med 2018 02 2;168(3):161-169. Epub 2018 Jan 2.

Tufts Medical Center, Boston, Massachusetts (V.K., J.T.C., J.B.W., P.J.N., D.M.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M17-1401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533918PMC
February 2018

A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1].

Value Health 2018 02;21(2):119-123

The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2017.12.012DOI Listing
February 2018

An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].

Value Health 2018 02;21(2):124-130

Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2017.12.006DOI Listing
February 2018

Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].

Value Health 2018 02;21(2):155-160

Department of General Internal Medicine, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10983015173389
Publisher Site
http://dx.doi.org/10.1016/j.jval.2017.12.011DOI Listing
February 2018

The influence of time horizon on results of cost-effectiveness analyses.

Expert Rev Pharmacoecon Outcomes Res 2017 Dec 23;17(6):615-623. Epub 2017 May 23.

a Center for the Evaluation of Value and Risk in Health , Institute for Clinical Research and Health Policy Studies, Tufts Medical Center , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2017.1331432DOI Listing
December 2017

The Potential Value of β-Amyloid Imaging for the Diagnosis and Management of Dementia: A Survey of Clinicians.

Alzheimer Dis Assoc Disord 2017 Jan-Mar;31(1):27-33

*Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA †Division of Geriatric Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA ‡Health Economics, GE Healthcare, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WAD.0000000000000168DOI Listing
November 2017

Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models.

Med Decis Making 2017 10 11;37(7):790-801. Epub 2017 Apr 11.

Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA (NO, JTC, PJN, JBW, DMK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X17704855DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577366PMC
October 2017

ICER's Revised Value Assessment Framework for 2017-2019: A Critique.

Pharmacoeconomics 2017 10;35(10):977-980

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, #063, 800 Washington St., Boston, MA, 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-017-0560-yDOI Listing
October 2017

Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease.

Alzheimers Dement 2017 Oct 5;13(10):1174-1178. Epub 2017 Sep 5.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2017.08.010DOI Listing
October 2017

A Call for Open-Source Cost-Effectiveness Analysis.

Ann Intern Med 2017 09 29;167(6):432-433. Epub 2017 Aug 29.

From Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M17-1153DOI Listing
September 2017

Drugs Cleared Through The FDA's Expedited Review Offer Greater Gains Than Drugs Approved By Conventional Process.

Health Aff (Millwood) 2017 08;36(8):1408-1415

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2016.1541DOI Listing
August 2017

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted.

PLoS One 2016 22;11(12):e0168512. Epub 2016 Dec 22.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168512PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179084PMC
July 2017

A Review of Empirical Analyses of Disinvestment Initiatives.

Value Health 2017 Jul - Aug;20(7):909-918. Epub 2017 May 16.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2017.03.015DOI Listing
July 2017

The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients.

Appl Health Econ Health Policy 2017 Feb;15(1):75-83

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Box #63, Boston, MA, 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40258-016-0269-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253145PMC
February 2017

Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value Frameworks.

Value Health 2017 02;20(2):193-199

Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2016.11.012DOI Listing
February 2017

Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy.

Pediatr Neurol 2017 01 15;66:69-75. Epub 2016 Sep 15.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pediatrneurol.2016.09.008DOI Listing
January 2017

Updated Recommendations for Cost-effectiveness Studies-Reply.

JAMA 2017 01;317(1):90

Rutgers University, New Brunswick, New Jersey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.17839DOI Listing
January 2017

Cost-Effectiveness Analysis 2.0.

N Engl J Med 2017 Jan;376(3):203-205

From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston (P.J.N.); and the Duke Clinical Research Institute, Duke University, Durham, NC (G.D.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1612619DOI Listing
January 2017

Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study.

Pharmacoeconomics 2016 12;34(12):1255-1265

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Box #63, Boston, MA, 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-016-0435-7DOI Listing
December 2016

Lack of Cost-Effectiveness Analyses to Address Healthy People 2020 Priority Areas.

Am J Public Health 2016 Dec 15;106(12):2205-2207. Epub 2016 Sep 15.

At the time this work was conducted, Peter J. Neumann, Megan Farquhar, Colby L. Wilkinson, and Mackenzie Lowry were with the Center for the Evaluation of Value and Risk in Health, Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA. Marthe Gold was with the New York Academy of Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2105/AJPH.2016.303361DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104986PMC
December 2016

Cost-effectiveness of adherence-enhancing interventions: a systematic review.

Expert Rev Pharmacoecon Outcomes Res 2016 3;16(1):67-84. Epub 2016 Feb 3.

a Department of Health Systems Management, Guilford-Glazer Faculty of Business and Management and Faculty of Health Sciences , Ben-Gurion University of the Negev , Beer-Sheva , Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2016.1138858DOI Listing
October 2016

Mapping US commercial payers' coverage policies for medical interventions.

Am J Manag Care 2016 Sep 1;22(9):e323-8. Epub 2016 Sep 1.

Tufts University School of Medicine, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, #63, Boston, MA 02111. E-mail:

View Article

Download full-text PDF

Source
September 2016

Cost-Effectiveness Analysis Expands its Reach Worldwide.

Value Health Reg Issues 2016 09 12;10:101-102. Epub 2016 Nov 12.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vhri.2016.10.001DOI Listing
September 2016

Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis.

J Am Geriatr Soc 2016 08 13;64(8):1549-57. Epub 2016 Jun 13.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.14227DOI Listing
August 2016

The impact of formulary drug exclusion policies on patients and healthcare costs.

Am J Manag Care 2016 08;22(8):524-31

Tufts University School of Medicine, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, #63, Boston, MA 02111. E-mail:

View Article

Download full-text PDF

Source
August 2016

The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology.

Expert Rev Pharmacoecon Outcomes Res 2015 19;15(6):931-40. Epub 2015 Oct 19.

a Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies , Tufts Medical Center , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2015.1102633DOI Listing
July 2016

The Role of Decision Models in Health Care Policy: A Case Study.

Med Decis Making 2016 07;36(5):666-79

Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Department of Health and Human Services, Rockville, MD, USA (AJ-B, CC, JS, WL)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X16646732DOI Listing
July 2016

Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007.

Med Care 2016 Apr;54(4):380-5

*Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA †Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC ‡Center for Health Solutions, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA §Patient Access and Outcomes, The Leukemia & Lymphoma Society, White Plains, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MLR.0000000000000496DOI Listing
April 2016

An assessment of the methodological quality of published network meta-analyses: a systematic review.

PLoS One 2015 29;10(4):e0121715. Epub 2015 Apr 29.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, #63, Boston, Massachusetts, 02111, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121715PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414531PMC
February 2016

Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic Review.

Am J Prev Med 2016 Feb 23;50(2):241-8. Epub 2015 Oct 23.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amepre.2015.08.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846573PMC
February 2016

Measuring the Value of Prescription Drugs.

N Engl J Med 2015 Dec 18;373(27):2595-7. Epub 2015 Nov 18.

From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1512009DOI Listing
December 2015

Price and value in cancer care.

Cancer 2015 Nov 6;121(22):4097-8. Epub 2015 Aug 6.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29625DOI Listing
November 2015

Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.

Am J Manag Care 2015 Sep;21(9):632-40

University of Washington School of Pharmacy, Box 357630, 1959 NE Pacific St, H-375A, Seattle, WA 98195. E-mail:

View Article

Download full-text PDF

Source
September 2015

Private payers disagree with Medicare over medical device coverage about half the time.

Health Aff (Millwood) 2015 Aug;34(8):1376-82

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and a professor of medicine in the School of Medicine, Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2015.0133DOI Listing
August 2015

When Does FDAMA Section 114 Apply? Ten Case Studies.

Value Health 2015 Jul 16;18(5):682-9. Epub 2015 Apr 16.

Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2015.02.013DOI Listing
July 2015

The lag from FDA approval to published cost-utility evidence.

Expert Rev Pharmacoecon Outcomes Res 2015 Jun 12;15(3):399-402. Epub 2015 Jan 12.

Tufts Medical Center, Center for the Evaluation of Value and Risk in Health, 800 Washington Street #63, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2015.1001371DOI Listing
June 2015

Medicare's Interventions Coverage: The Authors Reply.

Health Aff (Millwood) 2015 Jun;34(6):1066

Tufts Medical Center Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2015.0446DOI Listing
June 2015

The State of Cost-Utility Analyses in Asia: A Systematic Review.

Value Health Reg Issues 2015 May 24;6:7-13. Epub 2015 Mar 24.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vhri.2015.02.001DOI Listing
May 2015

Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study.

BMC Nephrol 2015 May 1;16:67. Epub 2015 May 1.

Division of Nephrology and Hypertension, Georgetown University School of Medicine, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12882-015-0059-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428114PMC
May 2015

Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses.

Blood 2015 Mar 5;125(12):1866-9. Epub 2015 Feb 5.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-07-592832DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366623PMC
March 2015

The changing face of the cost-utility literature, 1990-2012.

Value Health 2015 Mar 22;18(2):271-7. Epub 2015 Jan 22.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2014.12.002DOI Listing
March 2015

Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence.

Value Health 2015 Mar 7;18(2):308-14. Epub 2015 Feb 7.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2014.12.004DOI Listing
March 2015

Medicare's use of cost-effectiveness analysis for prevention (but not for treatment).

Health Policy 2015 Feb 22;119(2):156-63. Epub 2014 Nov 22.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Boston Scientific, Marlborough, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healthpol.2014.11.012DOI Listing
February 2015

Medicare is scrutinizing evidence more tightly for national coverage determinations.

Health Aff (Millwood) 2015 Feb;34(2):253-60

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and a professor at the Tufts University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2014.1123DOI Listing
February 2015

The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study.

Dement Geriatr Cogn Dis Extra 2014 Sep-Dec;4(3):494-508. Epub 2014 Dec 11.

Neurology, Institute of Clinical Medicine, Kuopio, Finland ; Neurology, NeuroCenter, Kuopio University Hospital, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000369159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296232PMC
February 2015

Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences.

Am J Manag Care 2015 Jan 1;21(1):e23-34. Epub 2015 Jan 1.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Box 63, Boston, MA 02111. E-mail:

View Article

Download full-text PDF

Source
January 2015

CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.

Int J Technol Assess Health Care 2015 Jan 11;31(5):347-54. Epub 2016 Jan 11.

Center for the Evaluation of Value and Risk in Health,Institute for Clinical Research and Health Policy Studies,Tufts Medical Center,Tufts University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462315000525DOI Listing
January 2015

Despite high costs, specialty drugs may offer value for money comparable to that of traditional drugs.

Health Aff (Millwood) 2014 Oct;33(10):1751-60

Peter J. Neumann is director of the Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, and a professor of medicine in the School of Medicine at Tufts University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2014.0574DOI Listing
October 2014

Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.

N Engl J Med 2014 Aug;371(9):796-7

From the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center (P.J.N., J.T.C.), and the Department of Health Policy and Management, Harvard School of Public Health (M.C.W.) - both in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1405158DOI Listing
August 2014

The value of specialty pharmaceuticals - a systematic review.

Am J Manag Care 2014 Jun;20(6):461-72

230 Third Ave, Waltham, MA 02451. E-mail:

View Article

Download full-text PDF

Source
June 2014

Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care.

Isr J Health Policy Res 2013 18;2:44. Epub 2013 Nov 18.

Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2045-4015-2-44DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843539PMC
May 2014

Is the US "leading from behind" on health policy?

Eur J Health Econ 2014 Mar 10;15(2):113-6. Epub 2013 Dec 10.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Box #063, Boston, MA, 02111, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10198-013-0548-2DOI Listing
March 2014

Where are we on "risk-sharing" agreements?

Authors:
Peter J Neumann

Value Health 2013 Jul-Aug;16(5):701-2. Epub 2013 Jun 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2013.04.012DOI Listing
November 2013

Willingness to pay for diagnostic technologies: a review of the contingent valuation literature.

Value Health 2013 Jul-Aug;16(5):797-805. Epub 2013 Jun 14.

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2013.04.005DOI Listing
November 2013

Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventions.

Value Health 2013 Jul-Aug;16(5):842-7. Epub 2013 Jul 11.

Department of Health Systems Management, Faculty of Health Sciences, and the Guilford Glazer Faculty of Business and Management, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2013.04.010DOI Listing
November 2013

A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topics.

Expert Rev Pharmacoecon Outcomes Res 2013 Oct;13(5):657-61

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington Street, Box #063, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2013.838027DOI Listing
October 2013

Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of US residents.

Expert Rev Pharmacoecon Outcomes Res 2013 Aug;13(4):513-22

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2013.814948DOI Listing
August 2013

Communicating and promoting comparative-effectiveness research findings.

Authors:
Peter J Neumann

N Engl J Med 2013 Jul;369(3):209-11

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1300312DOI Listing
July 2013

Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS).

Am J Kidney Dis 2013 Jun 15;61(6):947-56. Epub 2013 Jan 15.

Renal Division and Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2012.11.040DOI Listing
June 2013

Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain.

Health Aff (Millwood) 2013 Jun;32(6):1109-15

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, School of Medicine, Tufts University, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2012.1073DOI Listing
June 2013

Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures.

Value Health 2013 Jun 10;16(4):629-38. Epub 2013 May 10.

Health Economics Research Group, Brunel University, Uxbridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2013.02.011DOI Listing
June 2013

What can we learn from the U.S. expanded end-stage renal disease bundle?

Health Policy 2013 May 16;110(2-3):164-71. Epub 2013 Feb 16.

The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healthpol.2013.01.011DOI Listing
May 2013

The validity of dependence as a health outcome measure in Alzheimer's disease.

Am J Alzheimers Dis Other Demen 2013 May 19;28(3):245-52. Epub 2013 Mar 19.

Centre for Health Economics, University of York, Hesslington,York, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1533317513481092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690581PMC
May 2013

Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disorders.

Alzheimers Dement 2013 Jan;9(1):30-8

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2012.11.002DOI Listing
January 2013